Thread by @BrunoBrussels

Couple of things to note on Oxford-AstraZeneca and questions over exports from with implicit allegation that Britain has beggared its EU neighbours by withholding vaccines
UK has in fact suffered similar supply shortfalls - AZ a third of what was anticipated by end of Q1 2021

AZ, only approved vaccine being manufactured in the UK, has a decentralised manufacturing model. It's not-for-profit, low cost and open licensing as aim of scaling up global production quickly
UK tax-payer funded that development, enabled clinical trials & global manufacture

Hence the huge capacity being developed by Serum Institute of India in India or Australia's development of its own manufacturing. One of objectives of Oxford project was to ensure that AstraZeneca produced the vaccine for globally

Not a criticism but different from Pfizer-Biontech which is developing a centralised production model with global manufacturing taking place in Europe

So EU inevitably becomes preeminent exporter of vaccines as the global manufacturing base for the earliest approved jab. UK companies are part of the Pfizer manufacturing chain (contrary to some European claims) ft.com/content/a29be5…

Worth noting that given no UK restrictions the government has no way of officially knowing if AZ exports are made as there is no restricted list obliging pharma companies to report shipments (such as the EU's)